Monday, 26 August 2019

India News

  • India's resurgence as a clinical trial destination

    India |  News | By Aishwarya Venkatesh  | 0 Comment | 21 Sep, 2016

    Singapore: Factors such as technically competent workforce, large genetically diverse population, easy patient availability make India one of the most preferred destination for clinical tri...Read more

  • Eppendorf launches pipette calibration facility in India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Bangalore: Eppendorf, a leading life science company that develops and sells instruments, consumables and services, launched a Mobile Pipette Calibration facility in Chennai. This was launc...Read more

  • Columbia Asia receives $101mn investment from Mitsui & Co.

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2016

    Singapore: Columbia Asia has announced it is receiving $101 million in investment from Mitsui & Co., Ltd. Columbia Asia, part of Seattle-based Columbia Pacific Management, has 27 hospi...Read more

  • Lupin's sNDA Antara Capsules receive FDA nod

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 Oct, 2013

    Singapore: Indian drug major Lupin Limited's New Drug Application Antara capsules have received the US drug regulator's approval. The US Food and Drug Administration (FDA) provided its fin...Read more

  • "Solve Ranbaxy merger case in two days"

    India |  News | By BioSpectrum Bureau  | 0 Comment | 23 May, 2014

    Singapore: Now there is another twist to the interesting tale of merger of once powerful indigenous company, Ranbaxy by Sun Pharmaceutical Industries. The Supreme Court of India has asked t...Read more

  • Glenmark develops first-of-its-kind antibody

    India |  News | By BioSpectrum Bureau  | 0 Comment | 05 Feb, 2013

    Singapore: Glenmark Pharmaceuticals has started the discovery and initiation of IND enabling studies of a novel clinical development anti-OX40 monoclonal antibody. GBR 830.  The drug cand...Read more

  • Sanofi, Carlyle to buy Elder Pharma for $450 mn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 25 Jul, 2013

    Singapore: Sanofi's India unit and Carlyle group are in talks to buy the domestic drug formulation business of Indian drug major Elder Pharmaceuticals in a deal worth $400-to-450 million, a...Read more

  • India's Assam to launch miracle TB drug

    India |  News | By BioSpectrum Bureau  | 0 Comment | 08 Jun, 2016

    Singapore: As per reports, the Indian state of Assam has become the first state in Asia to launch a new drug that can combat multi-drug resistant tuberculosis. The drug, Bedaquiline (BDQ) c...Read more

  • New genomes of malaria sequenced, vaccine to follow

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    A group of scientists working in India and the US has sequenced and annotated the genomes of four Plasmodium vivax strains collected from disparate geographic locations in West Africa, Sout...Read more

  • Sri Lanka encourages Indian pharma companies to set up units in the country

    India |  News | By BioSpectrum Bureau  | 0 Comment | 13 Jul, 2016

    Singapore: In a bid to strengthen the pharma relations between the two countries, Sri Lankan Trade minister has planned a visit India, to encourage Indian pharmaceutical companies to establ...Read more

  • Indian govt relaxes clinical trial norms

    India |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2016

    Singapore: In a bid to woo global researchers and improve the clinical trial landscape in the country, the Indian government has decided to relax rules and ease clinical trial procedures in...Read more

  • India, Australia partner to foster sugar research

    India |  News | By BioSpectrum Bureau  | 0 Comment | 04 May, 2016

    Singapore: Sugar Research Australia recently announced a new research partnership with India to further research and foster the development of new sugarcane varieties. The team aims to focu...Read more

  • German firm Evotec to pack up from India

    India |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Singapore: Custom manufacturing German firm, Evotec is closing its Chemistry Operations in Thane, India. All chemistry efforts will now be performed at its Abingdon (UK) facility to answer ...Read more

  • Lambda appointed new president

    India |  News | By BioSpectrum Bureau  | 0 Comment | 18 Apr, 2016

    Singapore: Lambda Therapeutic Research announces the joining of Dr Tausif Monif as President - Global Operations. Lambda is a leading Global CRO in the Clinical research domain headquarter...Read more

  • Asia's first dental stem cell bank is here

    India |  Influencers | By BioSpectrum Bureau  | 1 Comment | 28 Oct, 2013

    With the experience of scientists having discovered the optimum medical therapeutic utilizing the nucleus of regenerative medicine - stem cell therapy, founders of India and Asia's first de...Read more

  • GSK sells thrombosis brands to Aspen for $1.1 bn

    India |  News | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: GlaxoSmithKline (GSK) has agreed to sell its thrombosis brands, Arixtra and Fraxiparine, and Notre-Dame de Bondeville (NDB) manufacturing site to South African pharmaceuticals co...Read more

  • Why are bio firms in a hurry to set up shop in Malaysia?

    India |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 Apr, 2013

    India-based Agila Biotech, which is a subsidiary of Strides Arcolab, entered into a $34.4 million (RM107 million) build-and-lease agreement with Malaysian Bio-Xcell, to set up a customized ...Read more

  • India's Arunachal Pradesh to get Digital Healthcare Centers

    India |  News | By BioSpectrum Bureau  | 0 Comment | 27 Jul, 2016

    Singapore: India's northeastern state of Arunachal Pradesh is wooing Samsung Electronics to set up units in the state. The state Chief Minister Mr Pema Khandu recently met representatives o...Read more



Podcast

 

Survey Box

Will APAC lead the way for innovation in the field of precision medicine?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls